MEI Pharma Inc (MEIP)

2.50 +0.05 (+2.01%) USD  |  NASDAQ  |  Dec 20, 16:00
2.49 -0.01 (-0.40%) After-Hours: 20:00
More

MEI Pharma Enterprise Value: -10.25M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for MEIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Evoke Pharma Inc 1.225M
Revance Therapeutics Inc 570.21M
NovaBay Pharmaceuticals Inc 1.870M
Palatin Technologies Inc 16.54M
iBio Inc 12.59M

Enterprise Value Related Metrics

Net Income (Quarterly) -8.007M
Total Expenses (Quarterly) 8.352M
EPS Diluted (Quarterly) -1.20
Earnings Yield -279.6%
Operating Earnings Yield 220.5%
Normalized Earnings Yield 244.50